SonarMD today presented positive results from two large, longitudinal studies evaluating several major drivers of medical costs in people living with Inflammatory Bowel Disease (IBD) – defined as people living with ulcerative colitis or Crohn's disease – and enrolled in the company's end-to-end, digital care coordination program.